Next Article in Journal
Virus-like Silica Nanoparticles Improve Permeability of Macromolecules across the Blood–Brain Barrier In Vitro
Previous Article in Journal
The Impact of Serum Protein Adsorption on PEGylated NT3–BDNF Nanoparticles—Distribution, Protein Release, and Cytotoxicity in a Human Retinal Pigmented Epithelial Cell Model
Previous Article in Special Issue
Dose Optimization and Targeting Strategies of Anti-Infective Agents
 
 
Article
Peer-Review Record

Meropenem PK/PD Variability and Renal Function: “We Go Together”

Pharmaceutics 2023, 15(9), 2238; https://doi.org/10.3390/pharmaceutics15092238
by Jacopo Angelini 1,2,*,†, Simone Giuliano 3,†, Sarah Flammini 3, Alberto Pagotto 3, Francesco Lo Re 1,2, Carlo Tascini 2,3 and Massimo Baraldo 1,2
Reviewer 1:
Reviewer 2:
Reviewer 3: Anonymous
Pharmaceutics 2023, 15(9), 2238; https://doi.org/10.3390/pharmaceutics15092238
Submission received: 28 July 2023 / Revised: 28 August 2023 / Accepted: 28 August 2023 / Published: 30 August 2023
(This article belongs to the Special Issue Dose Optimization and Targeting Strategies of Anti-infective Agents)

Round 1

Reviewer 1 Report

please provide higher resolution figures

Author Response

Dear Reviwer 1,

Thank you for your comment. I replaced the previous figure with a better resolution new figure .

 

Best regards,

J

Reviewer 2 Report

Meropenem, a widely used antibiotic, is impacted by renal function variability among patients, necessitating therapeutic drug monitoring (TDM) for personalized dosing. TDM-guided treatment is vital in combating severe infections and antimicrobial resistance, spanning various clinical settings to enhance efficacy in antibiotic administration. The authors described it in details and the writing is good. It can be accepted after the following queries being addressed.

Please clarify the following:

1. What will be the effect of similar alternative drugs for meropenem?

2. What will be the impact of the study in different geographical locations? 

3. It would be better if the authors could include some experimental data e.g., HPLC, etc. to support the claims. Otherwise, there will be always doubt in the reader's mind about the conclusions drawn in this type of study. (The authors also mentioned the same) 

4. Please fix Figure 1, the resolution is very poor.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 3 Report

This study on meropenem is recommended for publication in Pharmaceutics for its clinical meanings. Some  comments are shown as followings:

1. How did the authors calculate the correlation between creatinine clearance and meropenem exposure?

2. Figure 1b is blurred.

3. Statistical difference analysis should be provided for Figure 3 and 4.

Author Response

Please see the attachment

Author Response File: Author Response.docx

Back to TopTop